• Company
  • Description
  • Recovery Amount
  • Medco Research
  • State of Wisconsin Investment Board v. Bartlett, et al.


Delaware Chancery Court

In January 2000, G&E filed a shareholder derivative action on behalf of a large public pension fund against the directors of Medco Research, Inc., allegeing breach of fiduciary duty in connection with the directors’ approval of a proposed merger between Medco and King Pharmaceuticals, Inc. G&E was successful in obtaining a preliminary injunction requiring Medco to make supplemental and corrective disclosures. Because of G&E’s efforts, the consideration to Medco’s stockholders increased by $4.08 per share, or over $48 million on a class-wide basis.